Kevin Keane
Psychiatric/Mental Health · Devon, PANPI 1417639469
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 39 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Neos Therapeutics, LP at 47.3% of the total. Reporting peaked in 2024 at $366 and has fallen 68.5% since, to $115 in 2025. That places this record below the midpoint for psychiatric/mental health clinicians in PA, where the typical reported total is $478.
Across 39 payments — averaging $14.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neos Therapeutics, LP$271
- Corium, LLC$128
- Noven Therapeutics, LLC$57
- AbbVie$46
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$38
- Axsome Therapeutics, Inc.$18
- plus $15 from 1 others
What the payments were for
- Food & beverage$574100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neos Therapeutics, LP | 18 | $271 |
| Corium, LLC | 11 | $128 |
| Noven Therapeutics, LLC | 3 | $57 |
| AbbVie | 3 | $46 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $38 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
How this compares
$574 in reported general payments places this provider in the 50th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.
See all psychiatric/mental health providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 14 | $199 |
| Clonazepam | 27 | $140 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Devon
- Christine MulliganDevon$16K
- Kimberly GarciaAllentown$573K
- Cortney SmithWashington$227K
- Britney KeplerPittsburgh$158K
- Kirstyn KamegBethel Park$136K
- Anna DipietroDowningtown$131K
- Deena MasciocchiLanghorne$71K
- Joseph GagnonChesterbrook$64K
- Michelle CohenWashington$62K
- Sharon KatzJenkintown$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.